Optimal Iron Management in Patients Receiving Erythropoietin Therapy
- 1 January 1998
- journal article
- Published by Wiley in Seminars in Dialysis
- Vol. 11 (1) , 10-13
- https://doi.org/10.1111/j.1525-139x.1998.tb00199.x
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Economic appraisal of maintenance parenteral iron administration in treatment of anaemia in chronic haemodialysis patientsNephrology Dialysis Transplantation, 1996
- Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementationAmerican Journal of Kidney Diseases, 1995
- Efficacy of oral iron therapy in patients receiving recombinant human erythropoietinAmerican Journal of Kidney Diseases, 1995
- Intravenous iron-sucrose complex to reduce epoetin demand in dialysis patientsThe Lancet, 1994
- Detection of functional iron deficiency during erythropoietin treatment: a new approach.BMJ, 1992
- Iron in CancerPathobiology, 1992
- FerritinBlood Reviews, 1990
- Correction of the Anemia of End-Stage Renal Disease with Recombinant Human ErythropoietinNew England Journal of Medicine, 1987
- The rationale for treating iron deficiency anemiaArchives of internal medicine (1960), 1984
- DO PREGNANT WOMEN TAKE THEIR IRON ?The Lancet, 1969